<b>MODY is prevalent in later-onset diabetes, has potential for targeted therapy but is challenging to identify</b>

<p dir="ltr">Maturity Onset Diabetes of the Young (MODY) can present after the age of 40 years, but its prevalence, clinical characteristics, and the utility of simple clinical features for selecting cases in this age group remain poorly defined. We analysed whole-exome and clinical...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας:	Luke N Sharp (22551717) (author)
Άλλοι συγγραφείς:	Uyenlinh L Mirshahi (22551718) (author), Kevin Colclough (422231) (author), Timothy S Hall (22551719) (author), Jeremy S Haley (22551721) (author), Stuart J Cannon (22551727) (author), Thomas W Laver (22551731) (author), Michael N Weedon (21698) (author), Andrew T Hattersley (21706) (author), David J Carey (22551733) (author), Kashyap A Patel (22551735) (author)
Έκδοση:	2025
Θέματα:	Other biological sciences not elsewhere classified Monogenic Diabetes Maturity-Onset Diabetes of the Young (MODY) Genetics & Genomics Genetic Screening Late Onset
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

<b>MODY is prevalent in later-onset diabetes, has potential for targeted therapy but is challenging to identify</b>

Παρόμοια τεκμήρια